(Q28256162)

2

0 references

L I Szweda

3

0 references

Y Yang

4

0 references

J Bérard

5

0 references

J Seminaro

6

0 references

J Wu

European Journal of Immunology

7

0 references

language of work or name

English

0 references

publication date

November 1997

0 references

published in

0 references

volume

27

0 references

issue

11

0 references

page(s)

2781-6

0 references

cites work

TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

The effect of rapamycin on c-jun expression in human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Expression of a G-protein beta subunit-related gene during lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Rapamycin inhibits aldolase A expression during human lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

In vivo characterization of the proteasome regulator PA28

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Proteasomes: protein degradation machines of the cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

PA28 activator protein forms regulatory caps on proteasome stacked rings.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

A role for the proteasome regulator PA28alpha in antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Increase of cyclin B by overexpression of cystatin alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Degradation of G alpha by the N-end rule pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

The neuritogenesis inducer lactacystin arrests cell cycle at both G0/G1 and G2 phases in neuro 2a cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021

Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830271106

7 January 2021